1. A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancer. (August 2016) Authors: Hatfield, Stephen M; Sitkovsky, Michail Journal: Current opinion in pharmacology Issue: Volume 29(2016) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancer. (August 2016) Authors: Hatfield, Stephen M; Sitkovsky, Michail Journal: Current opinion in pharmacology Issue: Volume 29(2016) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Extracellular adenosine controls NKT‐cell‐dependent hepatitis induction. Issue 4 (19th February 2014) Authors: Subramanian, Meenakshi; Kini, Radhika; Madasu, Manasa; Ohta, Akiko; Nowak, Michael; Exley, Mark; Sitkovsky, Michail; Ohta, Akio Journal: European journal of immunology Issue: Volume 44:Issue 4(2014:Apr.) Page Start: 1119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Fluorinated Adenosine A2A Receptor Antagonists Inspired by Preladenant as Potential Cancer Immunotherapeutics. (19th October 2017) Authors: Yuan, Gengyang; Jankins, Tanner C.; Patrick, Christopher G.; Philbrook, Phaethon; Sears, Olivia; Hatfield, Stephen; Sitkovsky, Michail; Vasdev, Neil; Liang, Steven H.; Ondrechen, Mary Jo; Pollastri, Michael P.; Jones, Graham B. Other Names: Volpini Rosaria Academic Editor. Journal: International journal of medicinal chemistry Issue: Volume 2017(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗